首页> 美国卫生研究院文献>Biomicrofluidics >Insulator-based dielectrophoretic diagnostic tool for babesiosis
【2h】

Insulator-based dielectrophoretic diagnostic tool for babesiosis

机译:基于绝缘子的介电电泳诊断工具

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Babesia species are obligate intraerythrocytic tick-borne protozoan parasites that are the etiologic agents of babesiosis, a potentially life-threatening, malaria-like illness in humans and animals. Babesia-infected people have been known to suffer from complications including liver problems, severe hemolytic anemia, and kidney failure. As reported by the Food and Drug Administration, 38% of mortality cases observed in transfusion recipients were associated with transfusion transmitted diseases of which babesiosis is the chief culprit. As of now, no tests have been licensed yet for screening blood donors for babesiosis. Current diagnostic tools for babesiosis including enzyme-linked immunosorbent assay, fluorescence in situ hybridization, and polymerase chain reaction are expensive and burdened with multifarious shortcomings. In this research, a low-cost, high-specificity, quick, and easy-to-use insulator-based dielectrophoretic diagnostic tool is developed for characterizing and concentrating Babesia-infected cells in their homogenous mixture with healthy cell population. In this work, a mixture of Babesia-infected (varying parasitemia) and healthy red blood cells (RBCs or erythrocytes) was exposed to non-uniform electric fields in a fabricated microfluidic platform to manipulate and sort the Babesia-infected cells within a minute. At DC voltage configurations of 10 V and 0/6 V in the inlet and the two outlet channels, respectively, the diseased cells were seen to flow in a direction different from the healthy RBCs. Bright field and fluorescence microscopy were utilized to present qualitative differentiation of the healthy erythrocytes from the infected cells. The proposed micro device platform was able to enrich RBCs from 0.1% to ∼70% parasitemia. This device, when finally developed into a point-of-care diagnostic chip, would enhance the detection of Babesia-infected erythrocytes and as well serve as a precursor to babesiosis vaccine development.
机译:巴贝虫病是专性红细胞内tick传播的原生动物寄生虫,是巴贝虫病的病原体,巴贝虫病是一种潜在的威胁人类和动物的疟疾的疾病。众所周知,感染了贝贝虫病的人患有肝病,严重的溶血性贫血和肾衰竭等并发症。根据美国食品药品监督管理局的报告,在输血接受者中观察到的38%的死亡病例与输血传播的疾病有关,其中以婴儿病为主要罪魁祸首。截至目前,尚未有用于筛查献血者巴贝病的任何测试的许可。当前的针对杆状杆菌病的诊断工具包括酶联免疫吸附测定,荧光原位杂交和聚合酶链反应,价格昂贵,并且存在许多缺点。在这项研究中,开发了一种低成本,高特异性,快速且易于使用的基于绝缘子的介电泳诊断工具,用于表征和浓缩巴贝虫感染的细胞与健康细胞群的均匀混合物中的浓度。在这项工作中,感染巴贝虫病(多种寄生虫病)和健康红细胞(RBC或红细胞)的混合物在装配好的微流体平台上暴露于非均匀电场,以在一分钟内操纵和分选感染贝贝虫病的细胞。分别在入口通道和两个出口通道中的直流电压配置分别为10 V和0/6 V时,发现患病细胞的流动方向与健康RBC不同。利用明场和荧光显微镜观察健康红细胞与感染细胞的定性分化。拟议的微设备平台能够使红细胞的寄生虫血症从0.1%增至〜70%。最终将其开发为即时诊断芯片后,该设备将增强对巴贝虫病感染的红细胞的检测,并可以作为巴贝虫病疫苗开发的前身。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号